The Distributive Trades survey data from the UK is due on Monday, headlining a light day for the European economic news. At 2.00 am ET, Statistics Norway releases retail sales and household spending data.
Check-Cap Ltd. (CHEK) posted a third quarter net loss of $2.6 million, compared to a loss of $4.7 million, last year. Loss per share was $0.44 compared to a loss of $0.
German export expectations improved in November, survey data from the ifo institute showed Monday. The ifo export expectations indicator climbed to minus 3.8 points in November from minus 6.
Biotechnology company Krystal Biotech, Inc. (KRYS) announced Monday that the Company's Marketing Authorization Application (MAA) to the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) for VYJUVEK (beremagene geperpavec-svdt or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB) has been validated and is now under CHMP review.
Immuno-oncology company Genelux Corp. (GNLX) announced Monday that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the development program of Olvi-Vec (olvimulogene nanivacirepvec) for the treatment of patients with platinum resistant/refractory ovarian cancer.